Cargando…

Antiangiogenic Cancer Therapy

Detalles Bibliográficos
Autores principales:	Maxwell, P H, Ashcroft, M
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2009
Materias:	Book Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694434/ http://dx.doi.org/10.1038/sj.bjc.6605032

Ejemplares similares

Antiangiogenic therapy for breast cancer
por: Nielsen, Dorte Lisbet, et al.
Publicado: (2010)

Antiangiogenic therapy in breast cancer
por: Gampenrieder, Simon Peter, et al.
Publicado: (2017)

Antiangiogenic therapies in ovarian cancer
por: Reinthaller, Alexander
Publicado: (2016)

Antiangiogenic Steroids in Human Cancer Therapy
por: Pietras, Richard J., et al.
Publicado: (2005)

Escaping Antiangiogenic Therapy: Strategies Employed by Cancer Cells
por: Pinto, Mauricio P., et al.
Publicado: (2016)

Antiangiogenic Therapy for Glioma
por: Cea, Valentina, et al.
Publicado: (2012)

Antiangiogenic gene therapy of cancer: recent developments
por: Tandle, Anita, et al.
Publicado: (2004)

Interaction between Immunotherapy and Antiangiogenic Therapy for Cancer
por: Furukawa, Koichi, et al.
Publicado: (2020)

Antiangiogenic Therapy for Diabetic Nephropathy
por: Tanabe, Katsuyuki, et al.
Publicado: (2017)

Antiangiogenic therapy
por: Avitabile, T
Publicado: (2010)

Recent Advancements of Nanomedicine towards Antiangiogenic Therapy in Cancer
por: Mukherjee, Anubhab, et al.
Publicado: (2020)

Antiangiogenic therapy reverses the immunosuppressive breast cancer microenvironment
por: Chen, Wuzhen, et al.
Publicado: (2021)

New perspectives in glioblastoma antiangiogenic therapy
por: Popescu, Alisa Madalina, et al.
Publicado: (2015)

Safety profiles of current antiangiogenic therapies for metastatic colorectal cancer
por: Fuloria, Jyotsna
Publicado: (2012)

Challenges of antiangiogenic cancer therapy: trials and errors, and renewed hope
por: Medina, Miguel Ángel, et al.
Publicado: (2007)

Nanomaterials for Antiangiogenic Therapies for Cancer: A Promising Tool for Personalized Medicine
por: Alsaab, Hashem O., et al.
Publicado: (2021)

The inefficacy of antiangiogenic therapies
por: Ribatti, Domenico
Publicado: (2010)

Antiangiogenic therapies in urogenital malignancies: Fiction or fact?
por: Haidl, Friederike, et al.
Publicado: (2017)

Use of Antiangiogenic Therapies in Pediatric Solid Tumors
por: Ollauri-Ibáñez, Claudia, et al.
Publicado: (2021)

Recent Advances and Impact of Chemotherapeutic and Antiangiogenic Nanoformulations for Combination Cancer Therapy
por: Rajora, Amit Kumar, et al.
Publicado: (2020)

Novel concepts of antiangiogenic therapies in metastatic renal cell cancer
por: Pichler, Renate, et al.
Publicado: (2017)

Relationship between hypoxia and response to antiangiogenic therapy in metastatic colorectal cancer
por: Ulivi, Paola, et al.
Publicado: (2016)

Angiogenesis and antiangiogenic agents in cervical cancer
por: Tomao, Federica, et al.
Publicado: (2014)

Melatonin as an Adjuvant to Antiangiogenic Cancer Treatments
por: González, Alicia, et al.
Publicado: (2021)

Progress on Antiangiogenic Therapy for Patients with Malignant Glioma
por: Ahluwalia, Manmeet S., et al.
Publicado: (2010)

Combining antiangiogenic therapy and radiation in nasopharyngeal carcinoma
por: Chen, Zhuo, et al.
Publicado: (2015)

Antiangiogenic Strategies in Epithelial Ovarian Cancer: Mechanism, Resistance, and Combination Therapy
por: Jin, Chengwen, et al.
Publicado: (2022)

Modulation of Immunity by Antiangiogenic Molecules in Cancer
por: Terme, Magali, et al.
Publicado: (2012)

Antiangiogenic Therapy and Mechanisms of Tumor Resistance in Malignant Glioma
por: Rahman, Ruman, et al.
Publicado: (2010)

TGF-β Superfamily Receptors—Targets for Antiangiogenic Therapy?
por: Otten, Jasmin, et al.
Publicado: (2010)

Antiangiogenic mechanisms and factors in breast cancer treatment
por: Castañeda-Gill, Jessica M., et al.
Publicado: (2016)

Antiangiogenic Effect of Alkaloids
por: Alasvand, Masoud, et al.
Publicado: (2019)

Antiangiogenic therapy in diabetic nephropathy: A double-edged sword
por: Tao, Qian-Ru, et al.
Publicado: (2021)

Markers of Response to Antiangiogenic Therapies in Colorectal Cancer: Where Are We Now and What Should Be Next?
por: Cidon, E. Una, et al.
Publicado: (2016)

Sunitinib: the antiangiogenic effects and beyond
por: Hao, Zhonglin, et al.
Publicado: (2016)

Can we develop effective combination antiangiogenic therapy for patients with hepatocellular carcinoma?
por: Wenger, Justin B., et al.
Publicado: (2011)

Advances in antiangiogenic treatment of small-cell lung cancer
por: Lu, Hongyang, et al.
Publicado: (2017)

Antiangiogenic Therapy for Patients with Recurrent and Newly Diagnosed Malignant Gliomas
por: Shirai, Katsuyuki, et al.
Publicado: (2012)

Acquired tumor resistance to antiangiogenic therapy: Mechanisms at a glance
por: Zarrin, Bahare, et al.
Publicado: (2017)

Dexamethasone potentiates the antiangiogenic activity of docetaxel in castration-resistant prostate cancer
por: Wilson, C, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_q6nsakmri8bmliq9jidsgp66o0